327 related articles for article (PubMed ID: 28453696)
1. Epstein-Barr virus-associated gastric cancer reveals intratumoral heterogeneity of PIK3CA mutations.
Böger C; Krüger S; Behrens HM; Bock S; Haag J; Kalthoff H; Röcken C
Ann Oncol; 2017 May; 28(5):1005-1014. PubMed ID: 28453696
[TBL] [Abstract][Full Text] [Related]
2. Exon 9 Mutation of
Seo AN; Kang BW; Bae HI; Kwon OK; Park KB; Lee SS; Chung HY; Yu W; Jeon SW; Kang H; Kim JG
Anticancer Res; 2019 Apr; 39(4):2145-2154. PubMed ID: 30952761
[TBL] [Abstract][Full Text] [Related]
3. Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer.
Sukawa Y; Yamamoto H; Nosho K; Kunimoto H; Suzuki H; Adachi Y; Nakazawa M; Nobuoka T; Kawayama M; Mikami M; Matsuno T; Hasegawa T; Hirata K; Imai K; Shinomura Y
World J Gastroenterol; 2012 Dec; 18(45):6577-86. PubMed ID: 23236232
[TBL] [Abstract][Full Text] [Related]
4. Expression and prognostic roles of PIK3CA, JAK2, PD-L1, and PD-L2 in Epstein-Barr virus-associated gastric carcinoma.
Dong M; Wang HY; Zhao XX; Chen JN; Zhang YW; Huang Y; Xue L; Li HG; Du H; Wu XY; Shao CK
Hum Pathol; 2016 Jul; 53():25-34. PubMed ID: 26980034
[TBL] [Abstract][Full Text] [Related]
5. [Landscape of KRAS, BRAF, and PIK3CA Mutations and Clinical Features of EBV-Associated and Microsatellite Unstable Gastric Cancer].
Danishevich AM; Pospehova NI; Stroganova AM; Golovina DA; Nikulin MP; Kalinin AE; Nikolaev SE; Stilidi IS; Lyubchenko LN
Mol Biol (Mosk); 2023; 57(1):71-84. PubMed ID: 36976740
[TBL] [Abstract][Full Text] [Related]
6. Expression and significance of EBV, ARID1A and PIK3CA in gastric carcinoma.
Zhou H; Tan S; Li H; Lin X
Mol Med Rep; 2019 Mar; 19(3):2125-2136. PubMed ID: 30747208
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-associated gastric cancer: disease that requires special approach.
Ignatova E; Seriak D; Fedyanin M; Tryakin A; Pokataev I; Menshikova S; Vakhabova Y; Smirnova K; Tjulandin S; Ajani JA
Gastric Cancer; 2020 Nov; 23(6):951-960. PubMed ID: 32514646
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-associated gastric cancer: A distinct subtype.
Yang J; Liu Z; Zeng B; Hu G; Gan R
Cancer Lett; 2020 Dec; 495():191-199. PubMed ID: 32979463
[TBL] [Abstract][Full Text] [Related]
9. Morphological evidence of an activated cytotoxic T-cell infiltrate in EBV-positive gastric carcinoma preventing lymph node metastases.
van Beek J; zur Hausen A; Snel SN; Berkhof J; Kranenbarg EK; van de Velde CJ; van den Brule AJ; Middeldorp JM; Meijer CJ; Bloemena E
Am J Surg Pathol; 2006 Jan; 30(1):59-65. PubMed ID: 16330943
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer.
Park JH; Kim EK; Kim YH; Kim JH; Bae YS; Lee YC; Cheong JH; Noh SH; Kim H
Gastric Cancer; 2016 Oct; 19(4):1041-1051. PubMed ID: 26573601
[TBL] [Abstract][Full Text] [Related]
11. Novel Therapeutic Approaches for Epstein-Barr Virus Associated Gastric Cancer.
Kang BW; Baek DW; Kang H; Baek JH; Kim JG
Anticancer Res; 2019 Aug; 39(8):4003-4010. PubMed ID: 31366481
[TBL] [Abstract][Full Text] [Related]
12. Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas.
Luo B; Wang Y; Wang XF; Liang H; Yan LP; Huang BH; Zhao P
World J Gastroenterol; 2005 Feb; 11(5):629-33. PubMed ID: 15655811
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus positivity among surgically resected intramucosal gastric cancer.
Murai K; Kakushima N; Sugino T; Yoshida M; Kawata N; Tanaka M; Takizawa K; Muramatu K; Kusafuka K; Bando E; Ono H
Dig Endosc; 2018 Sep; 30(5):667-671. PubMed ID: 29729036
[TBL] [Abstract][Full Text] [Related]
14. PIK3CA mutation subtype delineates distinct immune profiles in gastric carcinoma.
Choi S; Kim H; Heo YJ; Kang SY; Ahn S; Lee J; Kim KM
J Pathol; 2023 Aug; 260(4):443-454. PubMed ID: 37341658
[TBL] [Abstract][Full Text] [Related]
15. Update on Epstein-Barr virus and gastric cancer (review).
Shinozaki-Ushiku A; Kunita A; Fukayama M
Int J Oncol; 2015 Apr; 46(4):1421-34. PubMed ID: 25633561
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-associated gastric carcinoma in Cali, Colombia.
Carrascal E; Koriyama C; Akiba S; Tamayo O; Itoh T; Eizuru Y; Garcia F; Sera M; Carrasquilla G; Piazuelo MB; Florez L; Bravo JC
Oncol Rep; 2003; 10(4):1059-62. PubMed ID: 12792770
[TBL] [Abstract][Full Text] [Related]
17. Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine.
Röcken C; Amallraja A; Halske C; Opasic L; Traulsen A; Behrens HM; Krüger S; Liu A; Haag J; Egberts JH; Rosenstiel P; Meißner T
Genome Med; 2021 Nov; 13(1):177. PubMed ID: 34749812
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of HER2 and downstream proteins in prediction of advanced tumor phenotypes and overall survival of patients with Epstein-Barr virus-positive vs. negative gastric cancers.
Zhang YW; He D; Tan C; Dong M; Zhou L; Shao CK
Pathol Res Pract; 2019 Nov; 215(11):152675. PubMed ID: 31594682
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral heterogeneity and loss of ARID1A expression in gastric cancer correlates with increased PD-L1 expression in Western patients.
Tober JM; Halske C; Behrens HM; Krüger S; Röcken C
Hum Pathol; 2019 Dec; 94():98-109. PubMed ID: 31704366
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-associated gastric carcinoma in Lima, Peru.
Yoshiwara E; Koriyama C; Akiba S; Itoh T; Minakami Y; Chirinos JL; Watanabe J; Takano J; Miyagui J; Hidalgo H; Chacon P; Linares V; Eizuru Y
J Exp Clin Cancer Res; 2005 Mar; 24(1):49-54. PubMed ID: 15943031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
